First-in-Human trial aims to sharpen medical scans
NCT ID NCT07253753
Summary
This is the first study in people to test a new imaging agent called NeuCaVis. The goal is to see if it is safe and how it moves through the body of healthy volunteers. Researchers hope this new agent will one day help doctors see inflammation in the brain and heart more clearly on PET scans than current methods allow.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.